Fereshteh Asgharzadeh
-
- Nigella sativa pharmacological applications 8
- Biological Psychiatry top 10%
- Toxicology top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 6
- Pharmacology top 10%
-
- Renin-Angiotensin System Studies 8
-
- Hormonal Regulation and Hypertension 7
-
- Nanoplatforms for cancer theranostics 5
-
- Inflammatory Bowel Disease 5
-
- Cancer Research and Treatments 4
-
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Majid KhazaeiMahmoud HosseiniSeyed Mahdi HassanianFarimah BeheshtiGordon A. FernsMehdi FarzadniaAmir AvanAlireza Hashemzadeh
- Journals
- Current Pharmaceutical Design (7 papers)Scientific Reports (3 papers)Toxicology and Applied Pharmacology (3 papers)
- Partner nations
- IranUnited KingdomUnited States
In The Last Decade
Fereshteh Asgharzadeh
67 papers receiving 858 citations
Peers
Comparison fields: 5 of 94
- Complementary and alternative medicine 132
- Biological Psychiatry 32
- Toxicology 28
- Biomaterials 103
- Pharmacology 61
Countries citing papers authored by Fereshteh Asgharzadeh
This map shows the geographic impact of Fereshteh Asgharzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fereshteh Asgharzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fereshteh Asgharzadeh more than expected).
Fields of papers citing papers by Fereshteh Asgharzadeh
This network shows the impact of papers produced by Fereshteh Asgharzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fereshteh Asgharzadeh. The network helps show where Fereshteh Asgharzadeh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fereshteh Asgharzadeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 14 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 14 | |
| 18 | 2020 | 3 | |
| 19 | 2019 | 23 | |
| 20 | 2017 | 13 |
About Fereshteh Asgharzadeh
Fereshteh Asgharzadeh is a scholar working on Complementary and alternative medicine, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 73 papers that have together received 868 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (8 papers), Nigella sativa pharmacological applications (8 papers), Hormonal Regulation and Hypertension (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers), Inflammatory Bowel Disease (5 papers), Cancer Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Complementary and alternative medicine (132 citations), Biological Psychiatry (32 citations) and Toxicology (28 citations). Fereshteh Asgharzadeh has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Majid Khazaei, Mahmoud Hosseini, Seyed Mahdi Hassanian, Farimah Beheshti, Gordon A. Ferns, Mehdi Farzadnia, Amir Avan, Amir Avan, Alireza Hashemzadeh and Hamid Reza Sadeghnia. Their work appears in journals such as Current Pharmaceutical Design, Scientific Reports, Toxicology and Applied Pharmacology, Journal of Drug Delivery Science and Technology and Research in Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.